Idiopathic hirsutism

R Azziz, E Carmina, ME Sawaya - Endocrine reviews, 2000 - academic.oup.com
Hirsutism, the presence of terminal (coarse) hairs in females in a male-like pattern, affects
between 5% and 10% of women. Of the sex steroids, androgens are the most important in …

Cyproterone acetate for hirsutism

ZM van der Spuy, PA Le Roux… - Cochrane Database …, 1996 - cochranelibrary.com
Background Hirsutism is a distressing and relatively common endocrine problem in women
which may prove difficult to manage. Cyproterone acetate, an anti‐androgen, is frequently …

Interventions for hirsutism (excluding laser and photoepilation therapy alone)

EJ van Zuuren, Z Fedorowicz… - Cochrane Database …, 2015 - cochranelibrary.com
Background Hirsutism occurs in 5% to 10% of women of reproductive age when there is
excessive terminal hair growth in androgen‐sensitive areas (male pattern). It is a distressing …

The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS)

KC Lewandowski, A Cajdler-Łuba… - Endokrynologia …, 2011 - journals.viamedica.pl
Introduction: Polycystic ovary syndrome (PCOS) is characterised by increased frequency of
hypothalamic GnRH pulses leading to a relative increase in LH synthesis by the pituitary. As …

Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause

AM Paoletti, S Floris, M Mannias, M Orrù… - The Journal of …, 2001 - academic.oup.com
The psychological symptoms assessed with a validated psychometric scale, SCL-90, were
significantly higher in postmenopausal women (PMW; 60 subjects) than in premenopausal …

Management of hirsutism

L Falsetti, A Gambera, C Platto, L Legrenzi - American journal of clinical …, 2000 - Springer
This review reports our own experience with, and literature studies of, the pharmacological
management of hirsutism in women with hyperandrogenism (polycystic ovary syndrome) or …

Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of …

KH Kelekci, S Kelekci, I Yengel, S Gul… - Journal of …, 2012 - Taylor & Francis
Objective: To compare the effectiveness of three different combinations of combined oral
contraceptives (COCs) and anti-androgens in the treatment of hirsutism. Methods: A total of …

The modern management of hirsutism

KS Oláh - Reviews in Gynaecological practice, 2004 - Elsevier
Hirsutism can be a have a major physical and psychological impact on a woman. To
understand the management of the hirsute woman, it is important to understand the hair …

Update on idiopathic hirsutism: diagnosis and treatment

C Erem - Acta Clinica Belgica, 2013 - Taylor & Francis
Idiopathic hirsutism (IH) is defined as hirsutism in conjunction with normal ovulatory function
and normal serum androgen levels. The pathogenesis of IH is still not clear. Increased …

Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives

I Wiegratz, H Kuhl - Treatments in endocrinology, 2002 - Springer
Cutaneous manifestations of hyperandrogenic disorders (acne, seborrhea, hirsutism and
androgenetic alopecia) can be caused by elevated levels of free testosterone or androgen …